The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 9th that its delegation participated in 'Bio Europe 2023,' the largest pharmaceutical and bio-pharma exhibition in Europe.
The event, held from the 6th to the 8th (local time) in Munich, Germany, registered over 5,700 participants, including experts from the pharmaceutical and bio-pharma industries and representatives of biotechnology clusters from more than 60 countries. South Korea ranked fourth in the number of participants, with a total of 470 people from 196 companies and institutions, demonstrating a strong commitment to global expansion and achieving results.
Lee Jae-guk, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, is delivering a greeting on behalf of the co-hosts at the "Korea-EU Networking Night," held as a side event of Bio Europe 2023 in Munich, Germany, on the 7th. (Photo by Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
During the event, the association's delegation engaged in partnering activities with pharmaceutical and bio-pharma-related associations and clusters from eight countries, including Germany, the United Kingdom, Sweden, and Belgium, explaining the capabilities and determination of Korea's pharmaceutical and bio-pharma industry and discussing future cooperation plans.
On the 6th, the delegation met with the Medicon Valley Alliance (MVA), a life sciences cluster spanning southern Sweden and eastern Denmark, to discuss information sharing and cooperation strategies. Both parties agreed to plan more concrete cooperation programs around Bio Europe 2024, which will be held in Stockholm, Sweden, next year.
On the 7th, the delegation held consecutive partnering meetings with Max Planck Innovation, a German basic science research and commercialization support institution that has produced multiple Nobel laureates; Bio-M, a bio cluster centered in southern Germany; and BioRN, a science innovation cluster based in western Germany. These meetings involved sharing the overall status of German life science clusters, trends in drug development advancements using artificial intelligence, and exploring practical cooperation measures going forward. Additionally, the delegation partnered with pharmaceutical and bio-pharma-related associations and clusters from the United Kingdom, Belgium, Switzerland, the Netherlands, Canada, and Taiwan.
Notably, on the evening of the 7th, the association hosted the 'Korea-EU Networking Night,' a standing dinner event designed as a platform for domestic and international pharmaceutical and bio-pharma experts participating in Bio Europe 2024 to interact. Co-hosted with the Korea Health Industry Development Institute (President Cha Sun-do) and the National Clinical Trial Support Foundation (Chairman Park In-seok), the event was attended by over 220 experts, including 130 from Korea and about 90 from overseas, fostering networking and discussions on mutual business cooperation, achieving great success.
On the final day of the event, the 8th, the association's delegation held a separate meeting with officials from KOTRA's Frankfurt and Zurich trade offices who visited the venue to discuss ways to support the entry of domestic pharmaceutical and bio-pharma companies into the European market. They also met with representatives from the Munich branch and life sciences division of the Korean Scientists and Engineers Association in Germany to expand networking aimed at supporting Korean companies' entry into Germany and enhancing mutual information exchange.
Lee Jae-guk, Executive Director of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, stated, "Through this event, we were able to confirm the global pharmaceutical companies' and institutions' interest in the competitiveness of Korea's pharmaceutical and bio-pharma industry." He added, "The association will continue to actively seek ways to help our companies achieve global results through successful partnerships with global big pharma and research institutes."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
